Skip to main content
Clinical Trials/CTRI/2018/06/014469
CTRI/2018/06/014469Completed未知

To Access The Clinical Efficacy Of Topical Tranexamic Acid With Microneedling In Melasma

Government medical college and hospital Chandigarh0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients with clinical diagnosis of melasma.

Exclusion Criteria

  • 1.Patients suffering from any significant systemic illness.
  • 2.Patient with known hypersensitivity to tranexamic acid.
  • 3.Patients with any other facial dermatoses.
  • 4. Patients on anticoagulants, oral contraceptive pills, hormone replacement therapy, NSAIDs, antiepileptic medications, isotretinoin or any other phototoxic medication.
  • 5. Pregnancy and lactation.
  • 6. History of thrombotic disease like DVT.

Investigators

Sponsor
Government medical college and hospital Chandigarh

Similar Trials